rapaflo

Generic: silodosin

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name rapaflo
Generic Name silodosin
Labeler allergan, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

silodosin 8 mg/1

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 0023-6142
Product ID 0023-6142_34eec0b8-ef99-4d69-bd3f-da1373da2e49
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022206
Marketing Start 2009-03-23
Marketing End 2026-03-31

Pharmacologic Class

Established (EPC)
alpha-adrenergic blocker [epc]
Mechanism of Action
adrenergic alpha-antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00236142
Hyphenated Format 0023-6142

Supplemental Identifiers

RxCUI
809477 809481 826612 826614
UNII
CUZ39LUY82
NUI
N0000000099 N0000175553

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rapaflo (source: ndc)
Generic Name silodosin (source: ndc)
Application Number NDA022206 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30)
source: ndc

Packages (1)

0023-6142-30 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30)

Ingredients (1)

silodosin (8 mg/1)

Linked Drug Pages (1)

RAPAFLO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "34eec0b8-ef99-4d69-bd3f-da1373da2e49", "openfda": {"nui": ["N0000000099", "N0000175553"], "unii": ["CUZ39LUY82"], "rxcui": ["809477", "809481", "826612", "826614"], "spl_set_id": ["da0314f6-b1d6-44ee-8b1e-f763dbb8613f"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30)", "package_ndc": "0023-6142-30", "marketing_end_date": "20260331", "marketing_start_date": "20090323"}], "brand_name": "RAPAFLO", "product_id": "0023-6142_34eec0b8-ef99-4d69-bd3f-da1373da2e49", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "0023-6142", "generic_name": "silodosin", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RAPAFLO", "active_ingredients": [{"name": "SILODOSIN", "strength": "8 mg/1"}], "application_number": "NDA022206", "marketing_category": "NDA", "marketing_end_date": "20260331", "marketing_start_date": "20090323"}